Delivery Order SPE2DB25D3012-SPE2DB25FWZTR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Veozah 45 mg tablets (30-count units) at a ceiling value of $1,582.61. This competitive award, which carries no set-aside designation, represents a firm fixed price delivery order and is expected to be completed by September 11, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,768.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count) on September 5, 2025, with an ultimate completion date of September 8, 2025. The contract is non-set-aside and competitively awarded, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,502.99 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count packages) on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value transaction typical of the agency's pharmaceutical procurement operations. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,976.56 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.24 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through...
- The Defense Logistics Agency awarded a delivery order valued at $16,183.30 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units). The award was made on September 8, 2025, with an ultimate completion date of September 9, 2025, under firm fixed price terms with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,432.43 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count packaging) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Veozah 45 mg tablets (30-count packages) under a firm fixed-price arrangement. The contract ceiling value is $6,509.38, with an ultimate completion date of July 31, 2025. This delivery order represents a non-set-aside, competitively awarded transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 17, 2025, for VEOZAH 45 mg tablets (30-count units) with a ceiling value of $2,227.38 under a firm fixed-price contract structure. This delivery order represents a competitive award with no set-aside designation, issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,254.01 for Veozah 45 mg tablets (30-count units) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price contract represents a non-competitive set-aside procurement for pharmaceutical supply to support federal medical needs. The award was fulfilled by AmerisourceBergen's Corporate Office division, with performance conducted at the company's Conshohocken,...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZTRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Veozah 45 mg tablets in quantities of 30 units. This competitive award, with a ceiling value of $6,521.93, represents a firm fixed-price delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is issued as a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion prime vendor vehicle valued through December 2026 that supports global pharmaceutical supply for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for the Department of Defense and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a non-set-aside competitive award, this delivery order reflects the company's proven ability to meet federal procurement requirements and further leverages its existing framework agreement with the Defense Logistics Agency to fulfill military healthcare pharmaceutical needs efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 9/3/25 |